Astera Labs (NASDAQ:ALAB) Trading 10.7% Higher – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price shot up 10.7% during trading on Monday . The company traded as high as $451.07 and last traded at $449.8450. 844,785 shares traded hands during trading, a decline of 85% from the average session volume of 5,677,063 shares. The stock had previously closed at $406.42.

Wall Street Analyst Weigh In

ALAB has been the topic of several research reports. Rothschild & Co Redburn assumed coverage on Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 target price on the stock. Stifel Nicolaus lifted their price objective on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Barclays increased their target price on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Citigroup cut Astera Labs from a “buy” rating to a “market perform” rating in a research note on Tuesday, May 26th. Finally, Susquehanna upped their price target on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $265.75.

Astera Labs Stock Performance

The firm has a 50-day moving average price of $322.82 and a two-hundred day moving average price of $209.73. The firm has a market cap of $65.63 billion, a price-to-earnings ratio of 258.71, a price-to-earnings-growth ratio of 4.97 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the prior year, the firm posted $0.33 earnings per share. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 400,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 2,164,441 shares of company stock valued at $526,198,280. 10.40% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Astera Labs

Hedge funds have recently modified their holdings of the business. Eurizon Capital SGR S.p.A. purchased a new stake in Astera Labs during the 4th quarter valued at approximately $18,708,000. Nordea Investment Management AB acquired a new position in shares of Astera Labs in the fourth quarter valued at approximately $2,028,000. Swedbank AB lifted its holdings in shares of Astera Labs by 76.8% during the fourth quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the period. Numerai GP LLC grew its position in Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after buying an additional 7,992 shares during the last quarter. Finally, Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in Astera Labs in the 4th quarter valued at $499,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.